paclitaxel has been researched along with Canine Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| An, JH; Chae, HK; Chu, SN; Kang, K; Oh, YI; Park, S; Seo, K; Youn, HY | 1 |
| An, JH; Chae, HK; Lee, IH; Son, MH; Song, WJ; Yang, JI; Youn, HY | 1 |
| Lechowski, R; Zabielska-Koczywąs, K | 1 |
| Baltezor, M; Bechtel, SM; Bryan, JN; Decedue, C; Espinosa, J; Flesner, BK; Henry, CJ; Rajewski, L; Selting, KA; Tate, D | 1 |
| Cartagena-Albertus, JC; Engel Manchado, J; Moise, A; Montoya Alonso, JA; Moya García, S | 1 |
| Asada, H; Fujino, Y; Goto-Koshino, Y; Ohno, K; Tomiyasu, H; Tsujimoto, H | 1 |
| Franciosi, AI; Guérios, SD; Pezzini, PC; Silva, DM | 1 |
| Axiak, SM; Bilof, KJ; Decedue, CJ; Henry, CJ; Howell, J; Kim, DY; Selting, KA; Tate, D | 1 |
| Borgå, O; Häggström, J; Nyman, H; Rivera, P; von Euler, H | 1 |
| Akerlund-Denneberg, N; Bergvall, K; Kastengren Fröberg, G; Kessler, M; Persson, G; Rivera, P; Rowe, A; von Euler, H; Westberg, S; Willmann, M | 1 |
| Bohling, CA; Forrest, LJ; Hershey, AE; Imondi, AR; Kurzman, ID; Placke, ME; Stonerook, M; Vail, DM | 1 |
| Beijnen, JH; Erjavec, Z; Mulder, NH | 1 |
| Ara, KY; Arai, K; Maruo, K; Matsuda, H; Uehara, K | 1 |
1 review(s) available for paclitaxel and Canine Diseases
| Article | Year |
|---|---|
The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.
Topics: Animals; Antibiotics, Antineoplastic; Cat Diseases; Cats; Cisplatin; Clinical Trials as Topic; Databases, Factual; Dog Diseases; Dogs; Doxorubicin; Drug Compounding; Liposomes; Nanoparticles; Neoplasms; Paclitaxel; Polyethylene Glycols | 2017 |
3 trial(s) available for paclitaxel and Canine Diseases
| Article | Year |
|---|---|
Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel.
Topics: Animals; Antidiarrheals; Antiemetics; Antineoplastic Agents, Phytogenic; Diarrhea; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Loperamide; Male; Neoplasms; Paclitaxel; Quinuclidines; Random Allocation; Vomiting | 2019 |
Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Clinical Trials, Phase I as Topic; Dog Diseases; Dogs; Drug Delivery Systems; Kidney; Liver; Nanoparticles; Neoplasms; Paclitaxel; Spleen; Tissue Distribution | 2011 |
Clinical efficacy and safety of a water-soluble micellar paclitaxel (Paccal Vet) in canine mastocytomas.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Dog Diseases; Dogs; Female; Infusions, Intravenous; Male; Mastocytoma; Paclitaxel; Prospective Studies; Quality of Life; Sweden; Treatment Outcome | 2013 |
9 other study(ies) available for paclitaxel and Canine Diseases
| Article | Year |
|---|---|
Retrospective analysis of efficacy and safety of oral paclitaxel for treatment of various cancers in dogs (2017-2021).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Humans; Neoplasms; Paclitaxel; Retrospective Studies | 2022 |
Use of oral paclitaxel for the treatment of bladder tumors in dogs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Dog Diseases; Dogs; Female; Male; Paclitaxel; Urinary Bladder Neoplasms | 2020 |
Evaluation of intravenous and subcutaneous administration of a novel, excipient-free, nanoparticulate formulation of paclitaxel in dogs with spontaneously occurring neoplasia.
Topics: Animals; Antineoplastic Agents, Phytogenic; Dog Diseases; Dogs; Drug Administration Schedule; Female; Infusions, Intravenous; Injections, Subcutaneous; Male; Nanoparticles; Neoplasm Recurrence, Local; Paclitaxel | 2018 |
Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Dog Diseases; Dogs; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Histiocytic Sarcoma; Melphalan; Methotrexate; Nimustine; Paclitaxel; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Vinblastine; Vincristine | 2015 |
Subcutaneous administration of paclitaxel in dogs with cancer: A preliminary study.
Topics: Animals; Carcinoma; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Lymphoma; Male; Mastocytoma; Paclitaxel; Sarcoma | 2015 |
A dose-finding study with a novel water-soluble formulation of paclitaxel for the treatment of malignant high-grade solid tumours in dogs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Dog Diseases; Dogs; Dosage Forms; Female; Male; Neoplasms; Paclitaxel; Survival Analysis | 2013 |
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Dog Diseases; Dogs; Doxorubicin; Female; Lung Neoplasms; Male; Melanoma; Paclitaxel; Sarcoma | 1999 |
A taste of taxol.
Topics: Alopecia; Animals; Antineoplastic Agents, Phytogenic; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Humans; Middle Aged; Paclitaxel; Saliva | 2001 |
Characterization of isotype-specific regions of five classes of canine beta-tubulin and their expression in several tissues and cell culture.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Dog Diseases; Dogs; Female; Gene Expression Regulation, Neoplastic; Male; Mammary Neoplasms, Animal; Mice; Mice, SCID; Molecular Sequence Data; Osteosarcoma; Paclitaxel; Polymerase Chain Reaction; Protein Isoforms; Sequence Homology, Amino Acid; Tubulin; Tumor Cells, Cultured | 2001 |